4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000164
Chairperson & CEO sold 9,500 shares at an average $539.99 ($5,129,873)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-14 | Sale : show line 2 in the form 10b5-1 | −40 | $526.07 | $21,043 | 333,903 | I |
| 2026-10-14 | Sale : show line 3 in the form 10b5-1 | −160 | $530.09 | $84,814 | 333,743 | I |
| 2026-10-14 | Sale : show line 4 in the form 10b5-1 | −120 | $531.19 | $63,742 | 333,623 | I |
| 2026-10-14 | Sale : show line 5 in the form 10b5-1 | −40 | $532.48 | $21,299 | 333,583 | I |
| 2026-10-14 | Sale : show line 6 in the form 10b5-1 | −240 | $534.63 | $128,312 | 333,343 | I |
| 2026-10-14 | Sale : show line 7 in the form 10b5-1 | −400 | $535.89 | $214,356 | 332,943 | I |
| 2026-10-14 | Sale : show line 8 in the form 10b5-1 | −633 | $537.19 | $340,039 | 332,310 | I |
| Open-market sales · 9,500 sh · avg $539.99 · $5,129,873 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-14 | Exercise or conversion : show line 18 in the form 10b5-1 Stock Option | −9,500 | 233,410 | I |
Loading xslF345X06/primarydocument.xml…